Company intelligence / Profile preview

Cohera Medical

Raleigh, North Carolina, United Statescoheramed.com ↗

Ownership: Private
Development stage: Other

Overview

Cohera Medical developed TissuGlu Surgical Adhesive, a resorbable, biocompatible adhesive designed to reduce fluid accumulation and eliminate the need for surgical drains after large flap surgeries. The product received CE Marking and was commercialized in Europe starting September 2011. In January 2015, it received FDA premarket approval as the first internal-use surgical adhesive of its kind in the US. The company also pursued additional indications such as bowel sealants and hernia mesh fixation but failed to secure further approvals before ceasing operations due to funding issues after a failed second product line.

Therapeutic areas: OtherGastroenterology
Modalities: Device (Surgical adhesive)Polymer-based medical device
Industry: Surgical Medical Devices

Partnerships

Pittsburgh Life Sciences Greenhouse

Beyond the preview

Go deeper on Cohera Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cohera Medical.